Biological Sample Collection for Research and Biobanking
NCT ID: NCT04270604
Last Updated: 2024-08-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
1279 participants
OBSERVATIONAL
2012-02-06
2023-11-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Through this research, scientists hope to identify future treatments or even cures.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
NCT02474160
Collecting and Storing Blood Samples From Patients With Cancer
NCT00900120
Biorepository for Precision Genomics
NCT02587026
Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members
NCT00071045
Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
NCT00582647
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Additionally, researchers perform genetic testing to learn more about DNA, a material in most cells that contains instructions for the body's development and functions (such as traits like eye color and risk of certain diseases). A piece of DNA that determines the specific role of a cell is called a "gene." If the instructions in a gene are abnormal, this can lead to disease.
Participation in the study involves: (1) completion of a health questionnaire, (2) providing a skin and/or blood sample from which stem cells may be created, (3) possible collection of a saliva sample for genetic analysis, and (4) possible future follow-up to provide additional information or learn about other research studies.
This study is not a clinical trial.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biological sample collection
Biological sample collection for biobanking and research
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years or older or
* Minor with parent/guardian consent
Biological Sample Collection
* Able and willing to provide:
* new samples of blood, skin, and/or saliva specifically for use in this study and/or
* excess/leftover samples, cell lines, and/or derivatives that were (or will be) collected for reasons other than this study
Exclusion Criteria
* Wards of the state
* For skin samples collected specifically for this study: history of keloid formation, bleeding disorder, allergy to the anesthetic, or anticoagulation use that precludes sample collection.
* For blood samples collected specifically for this study: bleeding disorder, or other medical condition, if the subject's condition increases the risks associated with blood collection.
* For saliva samples: inability to produce sufficient saliva or has a condition that precludes sample collection (such as severe trismus).
* For prospective samples: refuse to adhere to NYSCF's and/or collaborating site's COVID-19 safety protocols during the COVID-19 pandemic.
1 Month
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
New York Stem Cell Foundation Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Laura Andres-Martin
Senior Research Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laura Andres-Martin
Role: PRINCIPAL_INVESTIGATOR
New York Stem Cell Foundation Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York Stem Cell Foundation Research Institute
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
New York Stem Cell Foundation Website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20112091
Identifier Type: OTHER
Identifier Source: secondary_id
10-005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.